Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorunn Pauline Cavanagh

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Frontiers in Microbiology|September 26, 2019
Comparative Genomic Analysis of <i>Staphylococcus haemolyticus</i> Reveals Key to Hospital Adaptation and PathogenicityMaria Pain, Erik Hjerde, Claus Klingenberg, et al.
Journal of Clinical Microbiology|May 12, 2017
Bifidobacterium Bacteremia: Clinical Characteristics and a Genomic Approach To Assess PathogenicityEirin Esaiassen, Erik Hjerde, Jorunn Pauline Cavanagh, et al.
The Journal of Antibiotics|January 26, 2021
In vitro and in vivo antibacterial properties of peptide AMC-109 impregnated wound dressings and gelsJoakim Håkansson, Jorunn Pauline Cavanagh, Wenche Stensen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 8, 2016
Antimicrobial susceptibility and body site distribution of community isolates of coagulase-negative staphylococciJorunn Pauline Cavanagh, Runa Wolden, Philipp Heise, et al.
BMC Microbiology|April 9, 2020
Identification of surface proteins in a clinical Staphylococcus haemolyticus isolate by bacterial surface shavingRuna Wolden, Maria Pain, Roger Karlsson, et al.
Diagnostic Microbiology and Infectious Disease|December 17, 2017
Teicoplanin resistance in Staphylococcus haemolyticus is associated with mutations in histidine kinases VraS and WalKVladimir Vimberg, Jorunn Pauline Cavanagh, Oldřich Benada, et al.
Ebiomedicine|May 15, 2023
Development of early life gut resistome and mobilome across gestational ages and microbiota-modifying treatmentsAhmed Bargheet, Claus Klingenberg, Eirin Esaiassen, et al.
Microbiology Spectrum|October 31, 2023
The novel bacteriocin romsacin from <i>Staphylococcus haemolyticus</i> inhibits Gram-positive WHO priority pathogensRuna Wolden, Kirill V Ovchinnikov, Hermoine J Venter, et al.
Gut Microbes|September 29, 2020
Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiomeRasmus Goll, Peter Holger Johnsen, Erik Hjerde, et al.
The Lancet. Gastroenterology & Hepatology|November 5, 2017
Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trialPeter Holger Johnsen, Frank Hilpüsch, Jorunn Pauline Cavanagh, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Frontiers in Microbiology|September 26, 2019
Comparative Genomic Analysis of <i>Staphylococcus haemolyticus</i> Reveals Key to Hospital Adaptation and PathogenicityMaria Pain, Erik Hjerde, Claus Klingenberg, et al.
Journal of Clinical Microbiology|May 12, 2017
Bifidobacterium Bacteremia: Clinical Characteristics and a Genomic Approach To Assess PathogenicityEirin Esaiassen, Erik Hjerde, Jorunn Pauline Cavanagh, et al.
The Journal of Antibiotics|January 26, 2021
In vitro and in vivo antibacterial properties of peptide AMC-109 impregnated wound dressings and gelsJoakim Håkansson, Jorunn Pauline Cavanagh, Wenche Stensen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 8, 2016
Antimicrobial susceptibility and body site distribution of community isolates of coagulase-negative staphylococciJorunn Pauline Cavanagh, Runa Wolden, Philipp Heise, et al.
BMC Microbiology|April 9, 2020
Identification of surface proteins in a clinical Staphylococcus haemolyticus isolate by bacterial surface shavingRuna Wolden, Maria Pain, Roger Karlsson, et al.
Diagnostic Microbiology and Infectious Disease|December 17, 2017
Teicoplanin resistance in Staphylococcus haemolyticus is associated with mutations in histidine kinases VraS and WalKVladimir Vimberg, Jorunn Pauline Cavanagh, Oldřich Benada, et al.
Ebiomedicine|May 15, 2023
Development of early life gut resistome and mobilome across gestational ages and microbiota-modifying treatmentsAhmed Bargheet, Claus Klingenberg, Eirin Esaiassen, et al.
Microbiology Spectrum|October 31, 2023
The novel bacteriocin romsacin from <i>Staphylococcus haemolyticus</i> inhibits Gram-positive WHO priority pathogensRuna Wolden, Kirill V Ovchinnikov, Hermoine J Venter, et al.
Gut Microbes|September 29, 2020
Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiomeRasmus Goll, Peter Holger Johnsen, Erik Hjerde, et al.
The Lancet. Gastroenterology & Hepatology|November 5, 2017
Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trialPeter Holger Johnsen, Frank Hilpüsch, Jorunn Pauline Cavanagh, et al.
Pageof 3